Paediatric Active Enhanced Disease Surveillance (PAEDS) annual report 2015: Prospective hospital-based surveillance for serious paediatric conditions
DOI:
https://doi.org/10.33321/cdi.2017.41.37Keywords:
paediatric, surveillance, hospital, vaccine preventable diseases, adverse event following immunisation, acute flaccid paralysis, encephalitis, influenza, intussusception, pertussis, varicella zoster virusAbstract
Introduction: The Paediatric Active Enhanced Disease Surveillance (PAEDS) network is a hospital-based active surveillance system employing prospective case ascertainment for selected serious childhood conditions, particularly vaccine preventable diseases and potential adverse events following immunisation (AEFI). PAEDS data is used to better understand these conditions, inform policy and practice under the National Immunisation Program, and enable rapid public health responses for certain conditions of public health importance. PAEDS enhances data available from other Australian surveillance systems by providing prospective, detailed clinical and laboratory information on children with selected conditions. This is the second of the planned annual PAEDS reporting series, and presents surveillance data for 2015.
Methods: Specialist surveillance nurses screened hospital admissions, emergency department records, laboratory and other data, on a daily basis in 5 paediatric tertiary referral hospitals in New South Wales, Victoria, South Australia, Western Australia and Queensland to identify children with the selected conditions. Standardised protocols and case definitions were used across all sites. Conditions under surveillance in 2015 included acute flaccid paralysis (a syndrome associated with poliovirus infection), acute childhood encephalitis (ACE), influenza, intussusception (IS; a potential AEFI with rotavirus vaccines), pertussis and varicella-zoster virus infection (varicella and herpes zoster). Most protocols restrict eligibility to hospitalisations, ED only presentations are also included for some conditions.
Results: In 2015, there were 674 cases identified across all conditions under surveillance. Key outcomes of PAEDS included: contribution to national AFP surveillance to reach WHO reporting targets; identification of signals for Mycoplasma pneumoniae and parechovirus-related outbreaks (ACE surveillance); and demonstration of high influenza activity with vaccine effectiveness (VE) analysis supportive of vaccination. Surveillance for IS remains ongoing with any identified AEFIs reported to the relevant State Health Department; varicella and herpes zoster case numbers decreased slightly from previous years in older children not eligible for catch-up. Pertussis case numbers increased in early 2015 and analysis of cases in children aged <1 year demonstrated the importance of timely childhood and maternal immunisation.
Conclusions: PAEDS continues to provide unique policy-relevant data on serious paediatric conditions using hospital-based sentinel surveillance.
Downloads
References
Zurynksi YA, McRae J, Quinn HE, Wood NJ, Macartney K. Paediatric Active Enhanced Disease Surveillance (PAEDS) inaugural report 2014: prospective hospital-based surveillance for select vaccine preventable diseases and adverse events following immunisation. Commun Dis Intell 2016;40(3):E391-E400.
Zurynski Y, McIntyre P, Booy R, Elliott EJ. Paediatric active enhanced disease surveillance: a new surveillance system for Australia. J Paediatr Child Health 2013;49(7):588-594.
Roberts JA, Hobday LK, Ibrahim A, Aitkin T, Thorley BR. Australian National Enterovirus Reference Laboratory annual report, 2013. Commun Dis Intell 2015;39(2):E208-E216.
World Health Organization, Polio Global Eradication Initiative. Surveillance. Available from: http://polioeradication.org/who-we-are/strategy/surveillance/
Paediatric Trials Network Australia. WebSpirit. 2016. Available from: http://www.ptna.com.au/index.php/webspirit
Britton PN, Dale RC, Booy R, Jones CA. Acute encephalitis in children: progress and priorities from an Australasian perspective. J Paediatr Child Health 2015;51(2):147-158.
Elliott EJ, Zurynski YA, Walls T, Whitehead B, Gilmour R, Booy R. Novel inpatient surveillance in tertiary paediatric hospitals in New South Wales illustrates impact of first-wave pandemic influenza A H1N1 (2009) and informs future health service planning. J Paediatr Child Health 2012;48(3):235-241.
Bines JE, Kohl KS, Forster J, Zanardi LR, Davis RL, Hansen J, et al. Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine 2004;22(5-6):569-574.
Buttery JP, Danchin MH, Lee KJ, Carlin JB, McIntyre PB, Elliott EJ, et al. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine 2011;29(16):3061-3066.
Quinn HE, Wood NJ, Cannings KL, Dey A, Wang H, Menzies RI, et al. Intussusception after monovalent human rotavirus vaccine in Australia: severity and comparison of using healthcare database records versus case confirmation to assess risk. Pediatr Infect Dis J 2014;33(9):959-965.
Carlin JB, Macartney KK, Lee KJ, Quinn HE, Buttery J, Lopert R, et al. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia’s National Immunization Program. Clin Infect Dis 2013;57(10):1427-1434.
Pillsbury A, Quinn HE, McIntyre PB. Australian vaccine preventable diseases epidemiological review series: Pertussis 2006-2012. Commun Dis Intell 2014;38(3):E179-E194.
Marshall H, Quinn H, Gidding H, Richmond P, Crawford N, Gold N, et al. Severe and complicated varicella in the post-varicella vaccine era and associated genotypes. Presented at: 15th National Immunisation Conference; 7–9 June 2016; Brisbane.
Australian Bureau of Statistics (ABS). Population by age and sex, regions of Australia, 2015. (Cat. No. 3235.0). Canberra: ABS; 2016. Available from: http://www.abs.gov.au/AUSSTATS/abs@.nsf/Latestproducts/3235.0Main%20Features102015?opendocument&tabname=Summary&prodno=3235.0&issue=2015&num=&view=.
Wood N, Quinn H, Marshall H, Comeau J, Elliott E, Blyth C, et al. National study of infants <1 year of age hospitalised with pertussis: 2012–2015. Presented at: 15th National Immunisation Conference; 7–9 June 2016; Brisbane.
Desai S, Smith T, Thorley BR, Grenier D, Dickson N, Altpeter E, et al. Performance of acute flaccid paralysis surveillance compared with World Health Organization standards. J Paediatr Child Health 2015;51(2):209-214.
Britton PN, Dale RC, Elliott E, Festa M, Macartney K, Booy R, et al. Pilot surveillance for childhood encephalitis in Australia using the Paediatric Active Enhanced Disease Surveillance (PAEDS) network. Epidemiol Infect 2016;144(10):2117-2127.
Britton PN, Eastwood K, Brew BJ, Nagree Y, Jones CA. Consensus guidelines for the investigation and management of encephalitis. Med J Aust 2015;202(11):576-577.
Britton P, Dale R, Booy R, Blyth C, Crawford N, Marshall H, et al. Influenza-associated neurological disease: cases identified by the Australian Childhood Encephalitis (ACE) Study [poster abstract]. Open Forum Infect Dis 2015;2(Suppl 1):978.
Britton PN, Dale RC, Nissen MD, Crawford N, Elliott E, Macartney K, et al. Parechovirus encephalitis and neurodevelopmental outcomes. Pediatrics 2016;137(2):e20152848.
Britton PN, Eastwood K, Paterson B, Durrheim DN, Dale RC, Cheng AC, et al. Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and New Zealand. Intern Med J 2015;45(5):563-576.
Blyth CC, Macartney KK, Hewagama S, Senenayake S, Friedman ND, Simpson G, et al. Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2014: the Influenza Complications Alert Network (FluCAN). Euro Surveill 2016;21(30):pii=30301.
Jennings Z, Carter I, McPhie K, Kok J, Dwyer DE. Increased prevalence of influenza B/Victoria lineage viruses during early stages of the 2015 influenza season in New South Wales, Australia: implications for vaccination and planning. Euro Surveill 2015;20(31):pii=21201.
NCIRS. Significant events in influenza vaccination practice in Australia. 2016. Available from: http://ncirs.edu.au/assets/provider_resources/history/Influenza-history-November-2016.pdf
Australian Technical Advisory Group on Immunisation (ATAGI). The Australian immunisation handbook. 10th edn (2015 update). Canberra: Australian Government Department of Health; 2015.
Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014;384(9953):1521-1528.
Quinn HE, Snelling TL, Habig A, Chiu C, Spokes PJ, McIntyre PB. Parental Tdap boosters and infant pertussis: A case-control study. Pediatrics 2014;134(4):713-720.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2017 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
